Netherlands· NL-49ea7665957b

Imodium Duo 2 mg/125 mg, tabletten

A loperamid, kombinationen product containing loperamidehydrochloride + simeticon, registered in Netherlands by Kenvue Netherlands B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC A07DA53

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about loperamidehydrochloride + simeticonAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Loperamid, kombinationen is registered in 9 of 19 countries.

Countries holding a registration under ATC A07DA53 (loperamid, kombinationen), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
5 of them publish a price we can compare per daily dose

Search loperamid, kombinationen products by name

Loperamid, kombinationen · ATC A07DA53

9 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Ireland
Netherlands
Norwayprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LOPERAMIDEHYDROCHLORIDE + SIMETICON
Manufacturer: Kenvue Netherlands B.V.
Country: Netherlands (NL)
ATC code: A07DA53
ATC class: Loperamid, Kombinationen
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
33869

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A07DA53

Loperamid, kombinationen, as other registers publish it.

All loperamid, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4210a0dd-ae8f-494f-8804-8d06e7125e25
GET /v1/drugs/4210a0dd-ae8f-494f-8804-8d06e7125e25?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h33869_smpc.pdf",
  "strength": null,
  "atc_label": "Loperamide, Combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg33869",
  "excipients": [
    "ACESULFAAM KALIUM (E 950)",
    "BENZYLALCOHOL (E 1519)",
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "KUNSTMATIGE VANILLE SMAAKSTOF 598.536 TP05.51 FIRMENICH",
    "MALTODEXTRINE",
    "NATRIUMZETMEELGLYCOLAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "STEARINEZUUR (E 570)"
  ],
  "substances": [
    "LOPERAMIDEHYDROCHLORIDE",
    "SIMETICON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h33869.pdf",
  "authorised_at": "2007/04/12",
  "procedure_number": "DK/H/3047/001",
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "33869",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about loperamid, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console